Latest Molecular imaging Stories
The Pre-clinical imaging market is highly competitive, with each player vying to make a mark and gain a large market share.
The global market for molecular imaging devices was valued at $2 billion in 2012 and is expected to reach $2.2 billion in 2013.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.